SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Altimmune Q3 EPS $(0.74) Misses $(0.19) Estimate, Sales $640K Miss $2.63M Estimate

Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.19) by 289.47 percent. This is a 57.23 percent increase over losses of $(1.73) per share from the

Benzinga · -

Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.19) by 289.47 percent. This is a 57.23 percent increase over losses of $(1.73) per share from the same period last year. The company reported quarterly sales of $640 thousand which missed the analyst consensus estimate of $2.63 million by 75.67 percent. This is a 75.70 percent decrease over sales of $2.634 million the same period last year.